ABVC BioPharma Receives Australian TGA Approval to Initiate Phase II Study of Vitargus®
February 21, 2023 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...